“Findings: In this randomized trial that included 152 adult outpatients with confirmed COVID-19 and symptom onset within 7 days, clinical deterioration occurred in 0 patients treated with fluvoxamine vs 6 (8.3%) patients treated with placebo over 15 days, a difference that was statistically significant.”
Authors who wish to publish open access research articles in JAMA Network journals will be offered a Creative Commons (CC) license in exchange for payment of an article processing charge. The CC licenses, often required by funders, allow authors to retain copyright of their research articles. An open access article is free for everyone to read immediately and can be distributed without permission, provided that appropriate credit is given. Information provided by the author during the submission process will determine the appropriate CC license. Most authors will receive a CC-BY license, which offers the broadest reuse rights. Authors who report a commercial funding source will receive a CC-BY-NC-ND license.